61 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
13 May 24
Report of Foreign Private Issuer
7:03am
as study procedures. Dr. Lencioni, a key opinion leader in radiology of liver tumors, Department of Radiology, Pisa University School of Medicine Italy
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
15 Apr 24
A pivotal Phase III trial for advanced liver cancer, approved by FDA & EMA and a MASH Phase IIb are enrolling patients
7:03am
and additional liver diseases. Dr. Etzion is the Head, Department of Gastroenterology and Liver Diseases, at Soroka University Medical Center, Beer
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
24 Aug 23
Report of Foreign Private Issuer
7:19am
and require clinical studies with small number of patients
Dr. Antonella De Matteis, Professor of Biology, Department of Molecular Medicine … Matteis, Professor of Biology, Department of Molecular Medicine and Medical Biotechnology at the University of Naples Federico II, and Program Coordinator
6-K
EX-10.1
dtnb2y92z4
16 Aug 21
Report of Foreign Private Issuer
10:21am
6-K
EX-99.1
rs897a6j11414 k6yae
28 Jan 21
Report of Foreign Private Issuer
7:06am
F-6EF
sl3v9 rg42h1nkzwq1l
6 Nov 20
Automatic registration for ADRs (foreign)
4:32pm
6-K
EX-10.1
w42a4hxsh87xoxt
8 Jul 20
Report of Foreign Private Issuer
10:39am
6-K
EX-10.1
a1928ulcwx2jibh
12 Jun 20
Report of Foreign Private Issuer
8:03am
6-K
EX-10.1
0pwkh 5q3a
12 Feb 20
Report of Foreign Private Issuer
4:31pm
424B4
hket2pecyn34shgve
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
4vm0jjqwzvl
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1/A
EX-10.32
iabnzkzrv6nq4bs
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
qmrid9
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-10.1
40tmvh13j tk1bw
22 May 19
Report of Foreign Private Issuer
9:17am
6-K
EX-10.1
maj44gjp
4 Apr 19
Report of Foreign Private Issuer
9:17am